PER2 and central nervous system cancer: Later and in concordance with the previous report, Wang et al. (2014) analyzed the expression of PER2 in glioma samples by immunohistochemistry and found a significant reduction in PER2 expression associated with high-grade gliomas and higher expression of EGFR and PCNA.